Trial Outcomes & Findings for Use of a Distal Colonoscope Attachment to Increase Detection of Sessile Serrated Adenomas (NCT NCT03560037)

NCT ID: NCT03560037

Last Updated: 2025-09-22

Results Overview

Number of colonoscopies with at least one sessile serrated adenoma

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

427 participants

Primary outcome timeframe

Time point of assessment will be when pathology results are made available 2 weeks after procedure. Data will be collected through study completion, analyzed and reported up to 6 months after study completion.

Results posted on

2025-09-22

Participant Flow

Participant milestones

Participant milestones
Measure
Standard Colonoscopy
Patients randomly assigned to this group will receive standard colonoscopy without the use of a distal attachment.
Endocuff Vision Assisted Colonoscopy
Patients randomly assigned to this group will receive colonoscopy with the use of the Endocuff Vision distal attachment. Endocuff Vision Assisted Colonoscopy: Detachable device that is fixed to the end of colonoscope. The device has single-row of soft, hair-like projections that flatten colonic folds during colonoscope withdrawal which can aid in detection of colon polyps.
Overall Study
STARTED
216
211
Overall Study
COMPLETED
215
210
Overall Study
NOT COMPLETED
1
1

Reasons for withdrawal

Reasons for withdrawal
Measure
Standard Colonoscopy
Patients randomly assigned to this group will receive standard colonoscopy without the use of a distal attachment.
Endocuff Vision Assisted Colonoscopy
Patients randomly assigned to this group will receive colonoscopy with the use of the Endocuff Vision distal attachment. Endocuff Vision Assisted Colonoscopy: Detachable device that is fixed to the end of colonoscope. The device has single-row of soft, hair-like projections that flatten colonic folds during colonoscope withdrawal which can aid in detection of colon polyps.
Overall Study
Protocol Violation
1
0
Overall Study
Physician Decision
0
1

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Standard Colonoscopy
n=216 Participants
Patients randomly assigned to this group will receive standard colonoscopy without the use of a distal attachment.
Endocuff Vision Assisted Colonoscopy
n=211 Participants
Patients randomly assigned to this group will receive colonoscopy with the use of the Endocuff Vision distal attachment. Endocuff Vision Assisted Colonoscopy: Detachable device that is fixed to the end of colonoscope. The device has single-row of soft, hair-like projections that flatten colonic folds during colonoscope withdrawal which can aid in detection of colon polyps.
Total
n=427 Participants
Total of all reporting groups
Age, Continuous
57.2 years
STANDARD_DEVIATION 7.2 • n=216 Participants
57.9 years
STANDARD_DEVIATION 7.7 • n=211 Participants
57.6 years
STANDARD_DEVIATION 7.5 • n=427 Participants
Sex: Female, Male
Female
114 Participants
n=216 Participants
92 Participants
n=211 Participants
206 Participants
n=427 Participants
Sex: Female, Male
Male
102 Participants
n=216 Participants
119 Participants
n=211 Participants
221 Participants
n=427 Participants
Race and Ethnicity Not Collected
0 Participants
Race and Ethnicity were not collected from any participant.
Body Mass Index (BMI)
27.7 kg/m2
STANDARD_DEVIATION 4.9 • n=216 Participants
27.6 kg/m2
STANDARD_DEVIATION 4.6 • n=211 Participants
27.7 kg/m2
STANDARD_DEVIATION 4.8 • n=427 Participants
Alcohol consumption
Yes
153 Participants
n=216 Participants
145 Participants
n=211 Participants
298 Participants
n=427 Participants
Alcohol consumption
No
63 Participants
n=216 Participants
66 Participants
n=211 Participants
129 Participants
n=427 Participants
Smoking
Never
151 Participants
n=216 Participants
155 Participants
n=211 Participants
306 Participants
n=427 Participants
Smoking
Former
55 Participants
n=216 Participants
50 Participants
n=211 Participants
105 Participants
n=427 Participants
Smoking
Current
10 Participants
n=216 Participants
6 Participants
n=211 Participants
16 Participants
n=427 Participants

PRIMARY outcome

Timeframe: Time point of assessment will be when pathology results are made available 2 weeks after procedure. Data will be collected through study completion, analyzed and reported up to 6 months after study completion.

Population: Participants with complete colonoscopy

Number of colonoscopies with at least one sessile serrated adenoma

Outcome measures

Outcome measures
Measure
Standard Colonoscopy
n=215 Participants
Patients randomly assigned to this group will receive standard colonoscopy without the use of a distal attachment.
Endocuff Vision Assisted Colonoscopy
n=210 Participants
Patients randomly assigned to this group will receive colonoscopy with the use of the Endocuff Vision distal attachment. Endocuff Vision Assisted Colonoscopy: Detachable device that is fixed to the end of colonoscope. The device has single-row of soft, hair-like projections that flatten colonic folds during colonoscope withdrawal which can aid in detection of colon polyps.
Sessile Serrated Adenomas
42 colonoscopies
59 colonoscopies

SECONDARY outcome

Timeframe: Time point of assessment will be when pathology results are made available 2 weeks after procedure. Data will be collected through study completion, analyzed and reported up to 6 months after study completion.

Population: Participants with complete colonoscopy

Number of colonoscopies with at least one adenoma

Outcome measures

Outcome measures
Measure
Standard Colonoscopy
n=215 Participants
Patients randomly assigned to this group will receive standard colonoscopy without the use of a distal attachment.
Endocuff Vision Assisted Colonoscopy
n=210 Participants
Patients randomly assigned to this group will receive colonoscopy with the use of the Endocuff Vision distal attachment. Endocuff Vision Assisted Colonoscopy: Detachable device that is fixed to the end of colonoscope. The device has single-row of soft, hair-like projections that flatten colonic folds during colonoscope withdrawal which can aid in detection of colon polyps.
Adenoma Detection
159 colonoscopies
199 colonoscopies

SECONDARY outcome

Timeframe: Time point of assessment will be when pathology results are made available 2 weeks after procedure. Data will be collected through study completion, analyzed and reported up to 6 months after study completion.

Number of colonoscopies with at least one sessile serrated adenoma or conventional adenoma

Outcome measures

Outcome measures
Measure
Standard Colonoscopy
n=215 Participants
Patients randomly assigned to this group will receive standard colonoscopy without the use of a distal attachment.
Endocuff Vision Assisted Colonoscopy
n=210 Participants
Patients randomly assigned to this group will receive colonoscopy with the use of the Endocuff Vision distal attachment. Endocuff Vision Assisted Colonoscopy: Detachable device that is fixed to the end of colonoscope. The device has single-row of soft, hair-like projections that flatten colonic folds during colonoscope withdrawal which can aid in detection of colon polyps.
Proximal Colon Adenomas
83 colonoscopies
99 colonoscopies

SECONDARY outcome

Timeframe: Time point of assessment will be when pathology results are made available 2 weeks after procedure. Data will be collected through study completion, analyzed and reported up to 6 months after study completion.

Total adenomas detected in each treatment arm divided amongst the number of patients in each arm

Outcome measures

Outcome measures
Measure
Standard Colonoscopy
n=215 Participants
Patients randomly assigned to this group will receive standard colonoscopy without the use of a distal attachment.
Endocuff Vision Assisted Colonoscopy
n=210 Participants
Patients randomly assigned to this group will receive colonoscopy with the use of the Endocuff Vision distal attachment. Endocuff Vision Assisted Colonoscopy: Detachable device that is fixed to the end of colonoscope. The device has single-row of soft, hair-like projections that flatten colonic folds during colonoscope withdrawal which can aid in detection of colon polyps.
Adenomas Per Colonoscopy
0.96 adenomas per participant
Standard Deviation 1.33
1.24 adenomas per participant
Standard Deviation 1.67

SECONDARY outcome

Timeframe: Time point of assessment will be when pathology results are made available 2 weeks after procedure. Data will be collected through study completion, analyzed and reported up to 6 months after study completion.

Total sessile serrated adenomas in each treatment arm divided amongst the number of patients in each arm.

Outcome measures

Outcome measures
Measure
Standard Colonoscopy
n=215 Participants
Patients randomly assigned to this group will receive standard colonoscopy without the use of a distal attachment.
Endocuff Vision Assisted Colonoscopy
n=210 Participants
Patients randomly assigned to this group will receive colonoscopy with the use of the Endocuff Vision distal attachment. Endocuff Vision Assisted Colonoscopy: Detachable device that is fixed to the end of colonoscope. The device has single-row of soft, hair-like projections that flatten colonic folds during colonoscope withdrawal which can aid in detection of colon polyps.
Sessile Serrated Adenomas Per Colonoscopy
0.27 Sessile Serrated Adenomas Per Participan
Standard Deviation 0.59
0.35 Sessile Serrated Adenomas Per Participan
Standard Deviation 0.74

SECONDARY outcome

Timeframe: Time point of assessment will be when pathology results are made available 2 weeks after procedure. Data will be collected through study completion, analyzed and reported up to 6 months after study completion.

The total adenomas detected divided by the number of colonoscopies with at least one adenoma

Outcome measures

Outcome measures
Measure
Standard Colonoscopy
n=215 Participants
Patients randomly assigned to this group will receive standard colonoscopy without the use of a distal attachment.
Endocuff Vision Assisted Colonoscopy
n=210 Participants
Patients randomly assigned to this group will receive colonoscopy with the use of the Endocuff Vision distal attachment. Endocuff Vision Assisted Colonoscopy: Detachable device that is fixed to the end of colonoscope. The device has single-row of soft, hair-like projections that flatten colonic folds during colonoscope withdrawal which can aid in detection of colon polyps.
Adenomas Per Positive Colonoscopy
1.97 Adenomas Per Positive Colonoscopy
Standard Deviation 1.27
2.12 Adenomas Per Positive Colonoscopy
Standard Deviation 1.71

SECONDARY outcome

Timeframe: Time point of assessment will be when pathology results are made available 2 weeks after procedure. Data will be collected through study completion, analyzed and reported up to 6 months after study completion.

The total sessile serrated adenomas detected divided by the number of colonoscopies with at least one sessile serrated adenoma

Outcome measures

Outcome measures
Measure
Standard Colonoscopy
n=215 Participants
Patients randomly assigned to this group will receive standard colonoscopy without the use of a distal attachment.
Endocuff Vision Assisted Colonoscopy
n=210 Participants
Patients randomly assigned to this group will receive colonoscopy with the use of the Endocuff Vision distal attachment. Endocuff Vision Assisted Colonoscopy: Detachable device that is fixed to the end of colonoscope. The device has single-row of soft, hair-like projections that flatten colonic folds during colonoscope withdrawal which can aid in detection of colon polyps.
Sessile Serrated Adenomas (SSA) Per Positive Colonoscopy
1.20 SSA Per Positive Colonoscopy
Standard Deviation 0.63
1.48 SSA Per Positive Colonoscopy
Standard Deviation 0.82

SECONDARY outcome

Timeframe: Time point of assessment will be recorded at the time of colonoscopy. This data will be collected through study completion, analyzed and reported up to 6 months after study completion.

The time it takes to withdraw the colonoscope from the cecum to the end of the examination.

Outcome measures

Outcome measures
Measure
Standard Colonoscopy
n=215 Participants
Patients randomly assigned to this group will receive standard colonoscopy without the use of a distal attachment.
Endocuff Vision Assisted Colonoscopy
n=210 Participants
Patients randomly assigned to this group will receive colonoscopy with the use of the Endocuff Vision distal attachment. Endocuff Vision Assisted Colonoscopy: Detachable device that is fixed to the end of colonoscope. The device has single-row of soft, hair-like projections that flatten colonic folds during colonoscope withdrawal which can aid in detection of colon polyps.
Colonoscope Withdrawal Time
14.74 minutes
Standard Deviation 0.28
15.01 minutes
Standard Deviation 0.31

SECONDARY outcome

Timeframe: Time point of assessment will be recorded at the time of colonoscopy. This data will be collected through study completion, analyzed and reported up to 6 months after study completion.

Measurement of colon preparation based on the validated Boston Bowel Prep Score. Each colon segment (right, transverse, and left colons) will receive a score of 0 (worse) to 3 (best). The sum of each segment will be reported as a total score of 0 (worse) to 9 (best).

Outcome measures

Outcome measures
Measure
Standard Colonoscopy
n=215 Participants
Patients randomly assigned to this group will receive standard colonoscopy without the use of a distal attachment.
Endocuff Vision Assisted Colonoscopy
n=210 Participants
Patients randomly assigned to this group will receive colonoscopy with the use of the Endocuff Vision distal attachment. Endocuff Vision Assisted Colonoscopy: Detachable device that is fixed to the end of colonoscope. The device has single-row of soft, hair-like projections that flatten colonic folds during colonoscope withdrawal which can aid in detection of colon polyps.
Differences in Quality of Bowel Preparation
8.7 score on a scale (0 to 9)
Standard Deviation 0.8
8.7 score on a scale (0 to 9)
Standard Deviation 0.9

Adverse Events

Standard Colonoscopy

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Endocuff Vision Assisted Colonoscopy

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Christopher L. Bowlus, MD

University of California Davis

Phone: 916-734-8851

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place